Screening and Genomic Profiling of Antimicrobial Bacteria Sourced from Poultry Slaughterhouse Effluents: Bacteriocin Production and Safety Evaluation

Genes (Basel). 2024 Dec 2;15(12):1564. doi: 10.3390/genes15121564.

Abstract

Background/Objectives: Antimicrobial-resistant (AMR) pathogens represent a serious threat to public health, particularly in food production systems where antibiotic use remains widespread. As a result, alternative antimicrobial treatments to antibiotics are essential for effectively managing bacterial infections. This study aimed to identify and characterize novel antimicrobial peptides produced by bacteria, known as bacteriocins, as well as to recognize safe bacteriocin-producing strains, sourced from poultry slaughterhouse effluents. Methods: A total of 864 bacterial isolates were collected across eight stages of a poultry slaughter line and screened for antimicrobial activity against Gram-positive and Gram-negative indicator strains. Whole-genome sequencing (WGS) was performed on 12 selected strains, including Enterococcus faecium (6 isolates), Lactococcus lactis (1 isolate), Lactococcus garvieae (1 isolate) and Escherichia coli (4 isolates). The presence of bacteriocin gene clusters (BGC), antibiotic resistance genes (ARG), and virulence factors (VF) was analyzed. The antimicrobial activity of a novel bacteriocin was further evaluated using in vitro cell-free protein synthesis (IV-CFPS). Results: WGS revealed multiple BGCs, including a novel class IId bacteriocin, lactococcin P1A (LcnP1A), in L. lactis SWD9. LcnP1A showed antimicrobial activity against various indicator strains, including Listeria monocytogenes. While most bacteriocin-encoding strains harbored ARGs and VFs, E. faecium SWG6 was notable for its absence of ARGs and minimal VFs, highlighting its potential as a probiotic. Conclusions: These findings underscore the importance of discovering novel bacteriocins and safer bacteriocin producing strains to address antimicrobial resistance in the food chain. Further research would validate the efficacy of both the novel lactococcin P1A bacteriocin and the E. faecium SWG6 isolate for application in processed food and animal production systems.

Keywords: E. coli; Enterococcus faecium; Lactococcus garvieae; Lactococcus lactis; bacteriocins; colicin; enterocins; lactococcins; microcin.

MeSH terms

  • Abattoirs*
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacteriocins* / genetics
  • Bacteriocins* / pharmacology
  • Drug Resistance, Bacterial / genetics
  • Enterococcus faecium* / drug effects
  • Enterococcus faecium* / genetics
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Lactococcus / drug effects
  • Lactococcus / genetics
  • Lactococcus lactis / genetics
  • Lactococcus lactis / metabolism
  • Microbial Sensitivity Tests
  • Multigene Family
  • Poultry* / microbiology
  • Virulence Factors / genetics
  • Whole Genome Sequencing / methods

Substances

  • Bacteriocins
  • Anti-Bacterial Agents
  • Virulence Factors

Supplementary concepts

  • Lactococcus garvieae